Genome-wide association study identifies variants associated with histologic features of nonalcoholic fatty liver disease

Gastroenterology

Volumn 139, Issue 5, 2010, Pages

  Chalasani, Naga ^a   Guo, Xiuqing ^b   Loomba, Rohit ^c   Goodarzi, Mark O ^b   Haritunians, Talin ^b   Kwon, Soonil ^b   Cui, Jinrui ^b   Taylor, Kent D ^b   Wilson, Laura ^d   Cummings, Oscar W ^a   Chen, Yii Der Ida ^b   Rotter, Jerome I ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Farnesyl Diphosphate Farnesyl Transferase 1; GWAS; NASH; Nonalcoholic Steatohepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; FARNESYL DIPHOSPHATE; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CHROMOSOME 1; CHROMOSOME 10; CHROMOSOME 12; CHROMOSOME 18; CHROMOSOME 4; CHROMOSOME 7; CHROMOSOME 8; CLINICAL FEATURE; COHORT ANALYSIS; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; NONALCOHOLIC FATTY LIVER; PILOT STUDY; PRIORITY JOURNAL; QUANTITATIVE TRAIT; SINGLE NUCLEOTIDE POLYMORPHISM; STEATOSIS; WAIST HIP RATIO;

EID: 78049457761     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.07.057     Document Type: Article

References (44)

1. J.D. Browning, L.S. Szczepaniak, and R. Dobbins Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity Hepatology 40 2004 1387 1395
2. P. Angulo, J.C. Keach, K.P. Batts, and K.D. Lindor Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis Hepatology 30 1999 1356 1362
3. C.A. Matteoni, Z.M. Younossi, T. Gramlich, N. Boparai, Y.C. Liu, and A.J. McCullough Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity Gastroenterology 116 1999 1413 1419
4. M.F. Abdelmalek, C. Liu, J. Shuster, D.R. Nelson, and N.R. Asal Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease Clin Gastroenterol Hepatol 4 2006 1162 1169
5. R. Loomba, S.J. Hwang, and C.J. O'Donnell Parental obesity and offspring serum alanine and aspartate aminotransferase levels: the Framingham heart study Gastroenterology 134 2008 953 959
6. J.B. Schwimmer, M.A. Celedon, and J.E. Lavine Heritability of nonalcoholic fatty liver disease Gastroenterology 136 2009 1585 1592
7. N.M. Wilfred de Alwis, and C.P. Day Genetics of alcoholic liver disease and nonalcoholic fatty liver disease Semin Liver Dis 27 2007 44 54
8. J.L. Haines, M.A. Hauser, and S. Schmidt Complement factor H variant increases the risk of age-related macular degeneration Science 308 2005 419 421
9. A.O. Edwards, R. Ritter III, K.J. Abel, A. Manning, C. Panhuysen, and L.A. Farrer Complement factor H polymorphism and age-related macular degeneration Science 308 2005 421 424
10. R.J. Klein, C. Zeiss, and E.Y. Chew Complement factor H polymorphism in age-related macular degeneration Science 308 2005 385 389
11. K. Yamazaki, D. McGovern, and J. Ragoussis Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease Hum Mol Genet 14 2005 3499 3506
12. N.J. Samani, J. Erdmann, and A.S. Hall Genomewide association analysis of coronary artery disease N Engl J Med 357 2007 443 453 (Pubitemid 47204873)
13. X. Yuan, D. Waterworth, and J.R. Perry Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes Am J Hum Genet 83 2008 520 528
14. S. Romeo, J. Kozlitina, and C. Xing Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nat Genet 40 2008 1461 1465
15. D.E. Kleiner, E.M. Brunt, and M. Van Natta Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
16. K.L. Gunderson, F.J. Steemers, and G. Lee A genome-wide scalable SNP genotyping assay using microarray technology Nat Genet 37 2005 549 554
17. K.L. Gunderson, F.J. Steemers, and H. Ren Whole-genome genotyping Methods Enzymol 410 2006 359 376
18. S. Purcell, B. Neale, and K. Todd-Brown PLINK: a tool set for whole-genome association and population-based linkage analyses Am J Hum Genet 81 2007 559 575
19. Y. Rotman, C. Koh, J.M. Zmuda, D.E. Kleiner, T.J. Liang NASH CRN The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease [published online ahead of print on May 14, 2010] Hepatology 52 2010 894 903 10.1002/hep.23759
20. E.K. Speliotes, J.L. Butler, C. Palmer, B.F. Voight, J.N. Hirschhorn GIANT Consortium, the MIGen Consortium, the NASH CRN PNPLA3 variants specifically confer increased risk for histologic NAFLD but not metabolic disease [published online ahead of print on May 18, 2010] Hepatology 52 2010 904 912 10.1002/hep.23768
21. Y. Hochberg A sharper Bonferroni procedure for multiple tests of significance Biometrika 75 1988 800 802
22. S. Holm A simple sequentially rejective multiple test procedure Scand J Stat 6 1979 65 70
23. J.D. Storey A direct approach to false discovery rates J R Statist Soc B 64 2002 479 498
24. C. Johnson, T. Drgon, and Q.R. Liu Genome wide association for substance dependence: convergent results from epidemiologic and research volunteer samples BMC Med Genet 9 2008 113
25. I. Schechter, D.G. Conrad, and I. Hart Localization of the squalene synthase gene (FDFT1) to human chromosome 8p22-p23.1 Genomics 20 1994 116 118
26. G.C. Ness, Z. Zhao, and R.K. Keller Effect of squalene synthase inhibition on the expression of hepatic cholesterol biosynthetic enzymes, LDL receptor, and cholesterol 7 alpha hydroxylase Arch Biochem Biophys 311 1994 277 285
27. G.C. Ness, S. Eales, D. Lopez, and Z. Zhao Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression by sterols and nonsterols in rat liver Arch Biochem Biophys 308 1994 420 425
28. G. Malizia, E.M. Brunt, M.G. Peters, A. Rizzo, T.J. Broekelmann, and J.A. McDonald Growth factor and procollagen type I gene expression in human liver disease Gastroenterology 108 1995 145 156
29. J. Taipale, K. Miyazono, C.H. Heldin, and J. Keski-Oja Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein J Cell Biol 124 1994 171 181
30. M.J. Czaja, F.R. Weiner, and K.C. Flanders In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis J Cell Biol 108 1989 2477 2482
31. K. Yoshinaga, H. Obata, and V. Jurukovski Perturbation of transforming growth factor (TGF)-beta1 association with latent TGF-beta binding protein yields inflammation and tumors Proc Natl Acad Sci U S A 105 2008 18758 18763
32. A. Tuomisto, M. Sund, and J. Tahkola A mutant collagen XIII alters intestinal expression of immune response genes and predisposes transgenic mice to develop B-cell lymphomas Cancer Res 68 2008 10324 10332
33. Y. Zhang, Y. Gao, X. Zhang, W. Huang, and D. Zhu A Genome-wide Association Study of Hypertension and Blood Pressure in Chinese Population Circulation 120 2009 S555 Abstract 1781
34. T.Y. Ling, Y.H. Huang, M.C. Lai, S.S. Huang, and J.S. Huang Fatty acids modulate transforming growth factor-beta activity and plasma clearance FASEB J 17 2003 1559 1561
35. H. Hiyoshi, M. Yanagimachi, and M. Ito Squalene synthase inhibitors suppress triglyceride biosynthesis through the farnesol pathway in rat hepatocytes J Lipid Res 44 2003 128 135
36. Y. Wang, P.M. Rogers, C. Su, G. Varga, K.R. Stayrook, and T.P. Burris Regulation of cholesterologenesis by the oxysterol receptor, LXRalpha J Biol Chem 283 2008 26332 26339
37. E.G. Lund, J.G. Menke, and C.P. Sparrow Liver X receptor agonists as potential therapeutic agents for dyslipidemia and atherosclerosis Arterioscler Thromb Vasc Biol 23 2003 1169 1177
38. F. Thieringer, T. Maass, and P. Czochra Spontaneous hepatic fibrosis in transgenic mice overexpressing PDGF-A Gene 423 2008 23 28
39. M.M. Richardson, J.R. Jonsson, and E.E. Powell Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction Gastroenterology 133 2007 80 90
40. L. Ala-Kokko, T. Pihlajaniemi, J.C. Myers, K.I. Kivirikko, and E.R. Savolainen Gene expression of type I, III and IV collagens in hepatic fibrosis induced by dimethylnitrosamine in the rat Biochem J 244 1987 75 79
41. S. Naveau, T. Poynard, C. Benattar, P. Bedossa, and J.C. Chaput Alpha-2-macroglobulin and hepatic fibrosis Diagnostic interest Dig Dis Sci 39 1994 2426 2432
42. A. Philip, L. Bostedt, T. Stigbrand, and M.D. O'Connor-McCourt Binding of transforming growth factor-beta (TGF-beta) to pregnancy zone protein (PZP) Comparison to the TGF-beta-alpha 2-macroglobulin interaction Eur J Biochem 221 1994 687 693
43. S. Sookoian, G.O. Castano, A.L. Burgueno, T.F. Gianotti, M.S. Rosselli, and C.J. Pirola A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity J Lipid Res 50 2009 2111 2116
44. L. Valenti, A. Al-Serri, and A.K. Daly Homozygosity for the patalin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease Hepatology 51 2010 1209 1217